 FLORHAM PARK, N.J., Sept. 27, 2022 GLOBE NEWSWIRE -- Celularity Inc. Nasdaq: CELU Celularity, a clinical-stage biotechnology company developing placental-derived allogeneic cell therapies, today announced that Robert Hariri, M.D., Ph.D., Founder, Chairman and Chief Executive Officer of Celularity, will present at the Jefferies Cell and Genetic Medicine Summit on Friday, September 30, 2022 at 11 a.m. ET. 